BACKGROUND: Fluorescence imaging hardware (SPY) has recently been developed for intraoperative assessment of blood flow via detection of probes emitting in the near-infrared (NIR) spectrum. This study sought to determine if this imaging system was capable of detecting micrometastatic head and neck squamous cell carcinoma (HNSCC) in preclinical models. METHODS: A NIR fluorescent probe (IRDye800CW) was covalently linked to a monoclonal antibody targeting epidermal growth factor receptor (EGFR; panitumumab) or nonspecific IgG. HNSCC flank (SCC-1) and orthotopic (FADU and OSC19) xenografts were imaged 48-96 h after systemic injection of labeled panitumumab or IgG. The primary tumor and regional lymph nodes were dissected using fluorescence guidance with the SPY system and grossly assessed with a charge-coupled NIR system (Pearl). Histologic slides were also imaged with a NIR charged-coupled device (Odyssey) and fluorescence intensity was correlated with pathologic confirmation of disease. RESULTS: Orthotopic tongue tumors were clearly delineated from normal tissue with tumor-to-background ratios of 2.9 (Pearl) and 2.3 (SPY). Disease detection was significantly improved with panitumumab-IRDye compared to IgG-IRDye800 (P < 0.05). Tissue biopsy samples (average size 3.7 mm) positive for fluorescence were confirmed for pathologic disease by histology and immunohistochemistry (n = 25 of 25). Biopsy samples of nonfluorescent tissue were proven to be negative for malignancy (n = 28 of 28). The SPY was able to detect regional lymph node metastasis (<1.0 mm) and microscopic areas of disease. Standard histological assessment in both frozen and paraffin-embedded histologic specimens was augmented using the Odyssey. CONCLUSIONS: Panitumumab-IRDye800 may have clinical utility in detection and removal of microscopic HNSCC using existing intraoperative optical imaging hardware and may augment analysis of frozen and permanent pathology.
BACKGROUND: Fluorescence imaging hardware (SPY) has recently been developed for intraoperative assessment of blood flow via detection of probes emitting in the near-infrared (NIR) spectrum. This study sought to determine if this imaging system was capable of detecting micrometastatic head and neck squamous cell carcinoma (HNSCC) in preclinical models. METHODS: A NIR fluorescent probe (IRDye800CW) was covalently linked to a monoclonal antibody targeting epidermal growth factor receptor (EGFR; panitumumab) or nonspecific IgG. HNSCC flank (SCC-1) and orthotopic (FADU and OSC19) xenografts were imaged 48-96 h after systemic injection of labeled panitumumab or IgG. The primary tumor and regional lymph nodes were dissected using fluorescence guidance with the SPY system and grossly assessed with a charge-coupled NIR system (Pearl). Histologic slides were also imaged with a NIR charged-coupled device (Odyssey) and fluorescence intensity was correlated with pathologic confirmation of disease. RESULTS: Orthotopic tongue tumors were clearly delineated from normal tissue with tumor-to-background ratios of 2.9 (Pearl) and 2.3 (SPY). Disease detection was significantly improved with panitumumab-IRDye compared to IgG-IRDye800 (P < 0.05). Tissue biopsy samples (average size 3.7 mm) positive for fluorescence were confirmed for pathologic disease by histology and immunohistochemistry (n = 25 of 25). Biopsy samples of nonfluorescent tissue were proven to be negative for malignancy (n = 28 of 28). The SPY was able to detect regional lymph node metastasis (<1.0 mm) and microscopic areas of disease. Standard histological assessment in both frozen and paraffin-embedded histologic specimens was augmented using the Odyssey. CONCLUSIONS:Panitumumab-IRDye800 may have clinical utility in detection and removal of microscopic HNSCC using existing intraoperative optical imaging hardware and may augment analysis of frozen and permanent pathology.
Authors: Andries Zijlstra; Rebecca Mellor; Giano Panzarella; Ronald T Aimes; John D Hooper; Natalia D Marchenko; James P Quigley Journal: Cancer Res Date: 2002-12-01 Impact factor: 12.701
Authors: Eben L Rosenthal; Brian D Kulbersh; Ryan D Duncan; Wenyue Zhang; J Scott Magnuson; William R Carroll; Kurt Zinn Journal: Laryngoscope Date: 2006-09 Impact factor: 3.325
Authors: Kristen E Adams; Shi Ke; Sunkuk Kwon; Feng Liang; Zhen Fan; Yang Lu; Karen Hirschi; Michel E Mawad; Michael A Barry; Eva M Sevick-Muraca Journal: J Biomed Opt Date: 2007 Mar-Apr Impact factor: 3.170
Authors: Kirk P Withrow; John P Gleysteen; Ahmad Safavy; Joni Skipper; Renee A Desmond; Kurt Zinn; Eben L Rosenthal Journal: Otolaryngol Head Neck Surg Date: 2007-11 Impact factor: 3.497
Authors: John P Gleysteen; Ryan D Duncan; J Scott Magnuson; Joni B Skipper; Kurt Zinn; Eben L Rosenthal Journal: Cancer Biol Ther Date: 2007-05-03 Impact factor: 4.742
Authors: Brian D Kulbersh; Ryan D Duncan; J Scott Magnuson; Joni B Skipper; Kurt Zinn; Eben L Rosenthal Journal: Arch Otolaryngol Head Neck Surg Date: 2007-05
Authors: Jonathan T Elliott; Alisha V Dsouza; Scott C Davis; Jonathan D Olson; Keith D Paulsen; David W Roberts; Brian W Pogue Journal: Biomed Opt Express Date: 2015-09-03 Impact factor: 3.732
Authors: Allison S Cohen; Renata Patek; Steven A Enkemann; Joseph O Johnson; Tingan Chen; Eric Toloza; Josef Vagner; David L Morse Journal: Bioconjug Chem Date: 2015-10-30 Impact factor: 4.774
Authors: Eben L Rosenthal; Jason M Warram; Esther de Boer; Thomas K Chung; Melissa L Korb; Margie Brandwein-Gensler; Theresa V Strong; Cecelia E Schmalbach; Anthony B Morlandt; Garima Agarwal; Yolanda E Hartman; William R Carroll; Joshua S Richman; Lisa K Clemons; Lisle M Nabell; Kurt R Zinn Journal: Clin Cancer Res Date: 2015-04-22 Impact factor: 12.531
Authors: Tiara S Napier; Neha Udayakumar; Aditi H Jani; Yolanda E Hartman; Hailey A Houson; Lindsay Moore; Hope M Amm; Nynke S van den Berg; Anna G Sorace; Jason M Warram Journal: Mol Cancer Ther Date: 2020-06-30 Impact factor: 6.261
Authors: Larissa Sweeny; Andrew Prince; Neel Patel; Lindsay S Moore; Eben L Rosenthal; Brian B Hughley; Jason M Warram Journal: Laryngoscope Date: 2016-08-31 Impact factor: 3.325
Authors: Banghe Zhu; Grace Wu; Holly Robinson; Nathaniel Wilganowski; Mary A Hall; Sukhen C Ghosh; Kenneth L Pinkston; Ali Azhdarinia; Barrett R Harvey; Eva M Sevick-Muraca Journal: Mol Imaging Biol Date: 2013-10 Impact factor: 3.488
Authors: Kristine E Day; Lauren N Beck; Nicholas L Deep; Joy Kovar; Kurt R Zinn; Eben L Rosenthal Journal: Laryngoscope Date: 2013-04-24 Impact factor: 3.325
Authors: C Hope Heath; Nicholas L Deep; Lauren N Beck; Kristine E Day; Larissa Sweeny; Kurt R Zinn; Conway C Huang; Eben L Rosenthal Journal: Otolaryngol Head Neck Surg Date: 2013-03-22 Impact factor: 3.497